These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21335480)

  • 1. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes.
    Chan CW; Siu SC; Wong CK; Lee VW
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):57-64. PubMed ID: 21335480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults.
    Taveira TH; Dooley AG; Cohen LB; Khatana SA; Wu WC
    Ann Pharmacother; 2011 Nov; 45(11):1346-55. PubMed ID: 22028418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.
    John EJ; Vavra T; Farris K; Currie J; Doucette W; Button-Neumann B; Osterhaus M; Kumbera P; Halterman T; Bullock T
    Pharmacotherapy; 2006 Oct; 26(10):1511-7. PubMed ID: 16999661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving cholesterol target in a managed care organization (ACTION) trial.
    Straka RJ; Taheri R; Cooper SL; Smith JC
    Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
    Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
    Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong.
    Lee SS; Cheung PY; Chow MS
    J Clin Pharmacol; 2004 Jun; 44(6):632-9. PubMed ID: 15145971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong.
    Lee VW; Fan CS; Li AW; Chau AC
    J Clin Pharm Ther; 2009 Aug; 34(4):407-14. PubMed ID: 19583673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a structured health education programme by a diabetic education nurse on cardiovascular risk factors in Chinese Type 2 diabetic patients: a 1-year prospective randomized study.
    Ko GT; Li JK; Kan EC; Lo MK
    Diabet Med; 2004 Dec; 21(12):1274-9. PubMed ID: 15569128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus).
    Yamada C; Johnson JA; Robertson P; Pearson G; Tsuyuki RT
    Pharmacotherapy; 2005 Jan; 25(1):110-5. PubMed ID: 15767226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a patient-oriented education system for diabetes management.
    Lee TI; Yeh YT; Liu CT; Chen PL
    Int J Med Inform; 2007 Sep; 76(9):655-63. PubMed ID: 16815741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.
    Leung WY; So WY; Tong PC; Chan NN; Chan JC
    Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up study of programmed intervention of hyperuricemia in the prevention and treatment of cardiovascular morbid change].
    Zhu WH; Fang LZ; Chen LY; Chen ZW; Dai HL; Chen JH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):662-6. PubMed ID: 20450723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist intervention program for control of hypertension.
    Chabot I; Moisan J; Grégoire JP; Milot A
    Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.
    Ali F; Laurin MY; Larivière C; Tremblay D; Cloutier D
    Can J Clin Pharmacol; 2003; 10(3):101-6. PubMed ID: 14506507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case management for patients with poorly controlled diabetes: a randomized trial.
    Krein SL; Klamerus ML; Vijan S; Lee JL; Fitzgerald JT; Pawlow A; Reeves P; Hayward RA
    Am J Med; 2004 Jun; 116(11):732-9. PubMed ID: 15144909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.
    Gilani F; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH
    Ann Pharmacother; 2013 Jan; 47(1):43-8. PubMed ID: 23324512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk education and social support (CaRESS): report of a randomized controlled trial from the Kentucky Ambulatory Network (KAN).
    Pearce KA; Love MM; Shelton BJ; Schoenberg NE; Williamson MA; Barron MA; Houlihan JM;
    J Am Board Fam Med; 2008; 21(4):269-81. PubMed ID: 18612053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Web-based targeted nutrition counselling and social support for patients at increased cardiovascular risk in general practice: randomized controlled trial.
    Verheijden M; Bakx JC; Akkermans R; van den Hoogen H; Godwin NM; Rosser W; van Staveren W; van Weel C
    J Med Internet Res; 2004 Dec; 6(4):e44. PubMed ID: 15631968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.